A Single Dose of EGLN1 siRNA Yields Increased Erythropoiesis in Nonhuman Primates
Marc Abrams(Dicerna Pharmaceuticals (United States)), Dominique Stickens(Merck & Co., Inc., Rahway, NJ, USA (United States)), Marian E. Gindy(Merck & Co., Inc., Rahway, NJ, USA (United States)), Laura Sepp‐Lorenzino(Intellia Therapeutics (United States)), Julja Burchard(Rosetta Stone (United States)), Walter Strapps, Huseyin Mehmet(Merck & Co., Inc., Rahway, NJ, USA (United States)), Dennis M. Zaller(Merck & Co., Inc., Rahway, NJ, USA (United States)), Martin L. Koser(United States Military Academy)
Cited by 2
Related Papers
CRISPR-Cas9 In Vivo Gene Editing for Transthyretin Amyloidosis
|New England Journal of Medicine|2021|1.7k
Activated STING in a Vascular and Pulmonary Syndrome
|New England Journal of Medicine|2014|1.4k
Total Synthesis of Spirotryprostatin A, Leading to the Discovery of Some Biologically Promising Analogues
|Journal of the American Chemical Society|1999|463
Pharmacologic shifting of a balance between protein refolding and degradation mediated by Hsp90
|Proceedings of the National Academy of Sciences|1996|409